Comparison of Efficacy and Adverse Effects of 40% Hydrogen Peroxide and 50% Trichloroacetic Acid Preparations in the Treatment of Seborrheic Keratosis in A Tertiary Care Hospital

Authors

  • Sana Zafar Department of Dermatology, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Sumeera Zulfiqar Department of Dermatology, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Atika Raheem Department of Dermatology, Combined Military Hospital, Okara/National University of Medical Sciences (NUMS) Pakistan
  • Ayesha Kanwal Department of Dermatology, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Hina Mazhar Department of Dermatology, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Nigah-e-Mustafa Department of Dermatology, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-6.13806

Keywords:

Erythema, Hydrogen Peroxide, Keratosis, Seborrheic, Tertiary Care Centers, Trichloroacetic Acid

Abstract

Objective: To compare the efficacy and adverse effects of 40% Hydrogen Peroxide versus 50% Trichloroacetic Acid in the treatment of seborrheic keratosis in a tertiary care hospital.

Study Design: Quasi-experimental study.

Place and Duration of Study: Department of Dermatology, Combined Military Hospital, Lahore Pakistan, from Oct 2024 to Mar 2025.

Methodology: A total of 192 patients with seborrheic keratosis were enrolled in our study. After randomization, they were divided into two equal groups of 96 patients each. Group-A was treated with 40% Hydrogen Peroxide, and Group-B was treated with 50% Trichloroacetic Acid solution, for a maximum of four sessions at two-week intervals. The Physician’s Lesion Assessment score was used to assess therapeutic efficacy. Erythema and other localized skin reactions were also recorded during the four sessions and one month after completion of therapy.

Results: At the follow-up visit, n=33 (34.4%) of patients achieved a PLA score of 0 in Group-A, compared to n=12 (12.5%) of patients in Group-B. A statistically significant difference was observed between the two groups (p=0.001). Group-A had a lower frequency of localized skin reactions, including erythema (4%), burning (2%), crusting (2%), hyperpigmentation (2%), and pruritus (1%). In contrast, Group-B experienced a higher incidence of erythema (68%), burning (78%), and hyperpigmentation (3%).

Conclusion: Treatment with a 40% Hydrogen Peroxide solution is more effective for seborrheic keratosis than 50% Trichloroacetic Acid, while demonstrating a comparatively favorable side-effect profile.

Downloads

Download data is not yet available.

References

1. Myroshnychenko MS, Moiseienko TM, Torianyk Ivannik VY, Popova NG, Mozhaiev, et al. Seborrheic keratosis: current state of the problem. Wiad Lek 2022; 75(1 pt 2): 172-175.

https://doi.org/10.36740/wlek202201204

2. Kumar D, Das A, Bandyopadhyay D, Chowdhury SN, Das NK, Sharma P, et al. Dermatoses in the elderly: clinico-demographic profile of patients attending a tertiary care centre. Indian J Dermatol 2021; 66(1): 74-80.

https://doi.org/10.4103/ijd.ijd_245_20

3. Barthelmann S, Butsch F, Lang BM, Stege H, Großmann B, Schepler H, et al. Seborrheic keratosis. J Dtsch Dermatol Ges 2023; 21(3): 265-277. https://doi.org/10.1111/ddg.14984

4. Gorai S, Ahmad S, Raza SSM, Khan HD, Raza MA, Etaee F, et al. Update of pathophysiology and treatment options of seborrheic keratosis. Dermatol Ther 2022; 35(12): e15934.

https://doi.org/10.1111/dth.15934

5. Noushin S, Velusamy B, Thotli MKR, Rani TU, Sushrutha A, Makarand M, Safety and efficacy of 30% Hydrogen Peroxide in seborrheic keratoses – A prospective and interventional study, Asian J Med Sci 2024; 15(1): 84–89.

https://doi.org/10.71152/ajms.v15i1.3376

6. Agrawal D, Adil M, Amin SS, Mohtashim M, Bansal R, Tabassum H. Comparison of efficacy and safety of 30% Hydrogen Peroxide with 50% Trichloroacetic Acid in seborrheic keratosis: a randomized controlled study. Ital J Dermatol Venerol 2021; 156(4): 489-495.

https://doi.org/10.23736/s2784-8671.20.06518-9

7. Natarelli N, Krenitsky A, Hennessy K, Moore S, Grichnik J. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review. J Dermatolog Treat 2023; 34(1): 2133532. https://doi.org/10.1080/09546634.2022.2133532

8. Robertson S, Franko J. Hydrogen Peroxide 40% (Eskata) for seborrheic keratosis. Am Fam Physician 2019; 100(10): 643-644.

9. Salecha AJ, Samanthula H, Shaik FA, Jakkampudi A, Ruvva S. Comparative study of 40% Hydrogen Peroxide and 50% Trichloroacetic Acid in the treatment of seborrheic keratoses. J Pak Assoc Dermatol 2021; 30(4): 656-661.

https://doi.org/10.66344/jpad.30.4.2020.1467

10. DuBois JC, Jarratt M, Beger BB, Bradshaw M, Powala CV, Shanler SD. A-101, a proprietary topical formulation of high-concentration Hydrogen Peroxide solution: a randomized, double-blind, vehicle-controlled, parallel group study of the dose-response profile in subjects with seborrheic keratosis of the face. Dermatol Surg 2018; 44(3): 330-340.

https://doi.org/10.1097/dss.0000000000001302

11. Moscarella E, Brancaccio G, Briatico G, Ronchi A, Piana S, Argenziano G. Differential diagnosis and management on seborrheic keratosis in elderly patients. Clin Cosmet Investig Dermatol 2021; 14: 395-406.

https://doi.org/10.2147/ccid.s267246

12. Kao S, Kiss A, Efimova T, Friedman A. Ex vivo evaluation of cytotoxicity and melanocyte viability after A-101 Hydrogen Peroxide topical solution 40% or cryosurgery treatment in seborrheic keratosis lesions. J Am Acad Dermatol 2018; 79(4): 767-768. https://doi.org/10.1016/j.jaad.2018.03.034

13. Leskelä N, Huilaja L, Jokelainen J, Sinikumpu SP. Benign skin tumors in older persons:a population-based study. BMC Geriatr 2025; 25(1): 226.

https://doi.org/10.1186/s12877-025-05881-1

14. Suvarna P, Kayarkatte MN. Utility of 30% Hydrogen Peroxide in the treatment of seborrheic keratosis. Int J Dermatol 2022; 61(9): 1113-1116.

https://doi.org/10.1111/ijd.16096

15. Funkhouser CH, Coerdt KM, Haidari W, Cardis MA. Hydrogen Peroxide 40% for the treatment of seborrheic keratoses. Ann Pharmacother 2021; 55(2): 216-221.

https://doi.org/10.1177/1060028020941793

16. Mosbeh A, Aladl A. Cryotherapy versus Hydrogen Peroxide in the treatment of seborrheic keratosis. J Cosmet Dermatol Sci Appl 2023; 13: 62-75.https://doi.org/10.4236/jcdsa.2023.131007

17. Abd-Elshakour AAM, Maawad AN, Mansour AM, Dorgham HI. Comparison between Trichloroacetic Acid solution 50% and Hydrogen Peroxide solution 40% in cases diagnosed clinically and dermoscopically as seborrheic keratosis. Al-Azhar Int Med J 2025; 3: 168–174.

https://doi.org/10.21608/aimj.2025.446482

18. Sun MD, Halpern AC. Advances in the etiology, detection, and clinical management of seborrheic keratoses. Dermatology 2022; 238(2): 205-217.

https://doi.org/10.1159/000517070

19. Baumann LS, Blauvelt A, Draelos ZD, Kempers SE, Lupo MP, Schlessinger J, et al. Safety and efficacy of Hydrogen Peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302). J Am Acad Dermatol 2018; 79(5): 869-877.

https://doi.org/10.1016/j.jaad.2018.05.044

20. Smith SR, Xu S, Estes E, Shanler SD. Anatomic site-specific treatment response with 40% Hydrogen Peroxide (w/w) topical formulation for raised seborrheic keratoses: pooled analysis of data from two phase 3 studies. J Drugs Dermatol 2018; 17(10): 1092-1098.

Downloads

Published

29-05-2026

Issue

Section

Original Articles

Categories

How to Cite

1.
Zafar S, Zulfiqar S, Raheem A, Kanwal A, Mazhar H, Nigah-e-Mustafa. Comparison of Efficacy and Adverse Effects of 40% Hydrogen Peroxide and 50% Trichloroacetic Acid Preparations in the Treatment of Seborrheic Keratosis in A Tertiary Care Hospital. Pak Armed Forces Med J [Internet]. 2026 May 29 [cited 2026 Jun. 27];76(SUPPL-6):S894-S899. Available from: https://pafmj.org/PAFMJ/article/view/13806